Dose homogeneity as a function of source activity in optimized I-125 prostate implant treatment plans
- 15 November 2001
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 51 (4) , 1120-1130
- https://doi.org/10.1016/s0360-3016(01)01802-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- An iterative sequential mixed-integer approach to automated prostate brachytherapy treatment plan optimizationPhysics in Medicine & Biology, 2000
- A Survey of Physics and Dosimetry Practice of Permanent Prostate Brachytherapy in the United StatesInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Intensity modulated therapy and inhomogeneous dose to the tumor: A note of cautionInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic CarcinomaJournal of Urology, 1995
- Short-term freedom from disease progression after I-125 prostate implantationInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Quantifying the effect of dose inhomogeneity in brachytherapy: Application to permanent prostatic implant with 125I seedsInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Concept of dose nonuniformity in interstitial brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Evaluation of the substitution of Ir-192 seed ribbons for wires in Paris system using dose nonuniformity ratioInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Quantitative assessment of interstitial implantsInternational Journal of Radiation Oncology*Biology*Physics, 1991
- A dose homogeneity index for evaluating 192Ir interstitial breast implantsMedical Physics, 1988